CXM .65 (AMEX)-Biotech company whose chart is on watch with a pending 510K approval decision (estimated in March 2010). Decisions for the medical devices are very fluid and never specific dates involved. The lack of movement from the stock is because people don't know what to expect in way of approval with their device. This stock is near a 52 wk low!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.